1. Home
  2. RNXT vs MTEN Comparison

RNXT vs MTEN Comparison

Compare RNXT & MTEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • MTEN
  • Stock Information
  • Founded
  • RNXT 2012
  • MTEN 2015
  • Country
  • RNXT United States
  • MTEN China
  • Employees
  • RNXT N/A
  • MTEN N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • MTEN Building Products
  • Sector
  • RNXT Health Care
  • MTEN Industrials
  • Exchange
  • RNXT Nasdaq
  • MTEN Nasdaq
  • Market Cap
  • RNXT 35.2M
  • MTEN 29.3M
  • IPO Year
  • RNXT 2021
  • MTEN 2024
  • Fundamental
  • Price
  • RNXT $0.78
  • MTEN $2.03
  • Analyst Decision
  • RNXT Strong Buy
  • MTEN
  • Analyst Count
  • RNXT 2
  • MTEN 0
  • Target Price
  • RNXT $7.50
  • MTEN N/A
  • AVG Volume (30 Days)
  • RNXT 371.1K
  • MTEN 118.1K
  • Earning Date
  • RNXT 11-13-2025
  • MTEN 10-01-2025
  • Dividend Yield
  • RNXT N/A
  • MTEN N/A
  • EPS Growth
  • RNXT N/A
  • MTEN N/A
  • EPS
  • RNXT N/A
  • MTEN N/A
  • Revenue
  • RNXT $928,000.00
  • MTEN $10,735,337.00
  • Revenue This Year
  • RNXT $2,895.35
  • MTEN N/A
  • Revenue Next Year
  • RNXT $313.04
  • MTEN N/A
  • P/E Ratio
  • RNXT N/A
  • MTEN N/A
  • Revenue Growth
  • RNXT N/A
  • MTEN 16.63
  • 52 Week Low
  • RNXT $0.70
  • MTEN $1.80
  • 52 Week High
  • RNXT $1.69
  • MTEN $26.03
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 31.87
  • MTEN 21.42
  • Support Level
  • RNXT $0.91
  • MTEN $1.98
  • Resistance Level
  • RNXT $1.09
  • MTEN $2.50
  • Average True Range (ATR)
  • RNXT 0.09
  • MTEN 0.55
  • MACD
  • RNXT -0.02
  • MTEN 0.07
  • Stochastic Oscillator
  • RNXT 14.69
  • MTEN 2.22

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About MTEN Mingteng International Corporation Inc. Ordinary Shares

Mingteng International Corp Inc operates as an automotive mold developer and supplier in China. It provides an extensive product lineup including casting molds for turbocharger systems, braking systems, steering and differential systems, and other automotive system parts. Besides, it also produces molds for new energy electric vehicle motor drive systems, battery pack systems, and engineering hydraulic components, which are widely used in the automobile, construction machinery, and other manufacturing industries.

Share on Social Networks: